These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2219196)
1. Induction and inhibition of estradiol hydroxylase activities in MCF-7 human breast cancer cells in culture. Niwa T; Bradlow HL; Fishman J; Swaneck GE Steroids; 1990 Jul; 55(7):297-302. PubMed ID: 2219196 [TBL] [Abstract][Full Text] [Related]
2. Determination of estradiol 2- and 16-alpha-hydroxylase activities in MCF-7 human breast cancer cells in culture using radiometric analysis. Niwa T; Bradlow HL; Fishman J; Swaneck GE J Steroid Biochem; 1989 Aug; 33(2):311-4. PubMed ID: 2770303 [TBL] [Abstract][Full Text] [Related]
3. Metabolism of estradiol by human breast cancer. Abul-Hajj YJ; Thijssen JH; Blankenstein MA Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1171-8. PubMed ID: 3416901 [TBL] [Abstract][Full Text] [Related]
4. [Biological effect of estrogen metabolites in human breast cancer]. Imoto S Nihon Geka Gakkai Zasshi; 1992 May; 93(5):505-17. PubMed ID: 1614394 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of alpha-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells. Merchant M; Krishnan V; Safe S Toxicol Appl Pharmacol; 1993 Jun; 120(2):179-85. PubMed ID: 8390116 [TBL] [Abstract][Full Text] [Related]
6. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status. Angus WG; Larsen MC; Jefcoate CR Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772 [TBL] [Abstract][Full Text] [Related]
7. Elevated estrogen 16 alpha-hydroxylase activity: is this a genotoxic or nongenotoxic biomarker in human breast cancer risk? Nebert DW J Natl Cancer Inst; 1993 Dec; 85(23):1888-91. PubMed ID: 8230275 [No Abstract] [Full Text] [Related]
8. Impact of tamoxifen on peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11, cytochrome P450 3A2, and steroid 5 alpha-reductase. Chang TK; Chan MM; Holsmer SL; Bandiera SM; Bellward GD Biochem Pharmacol; 1996 Feb; 51(3):357-68. PubMed ID: 8573203 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279 [TBL] [Abstract][Full Text] [Related]
10. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the induction of DNA strand breaks and poly(ADP-ribose) polymerase-1 activation by 17beta-estradiol in human breast carcinoma cells through alteration of CYP1A1 and CYP1B1 expression. Lin PH; Lin CH; Huang CC; Fang JP; Chuang MC Chem Res Toxicol; 2008 Jul; 21(7):1337-47. PubMed ID: 18558727 [TBL] [Abstract][Full Text] [Related]
11. Influence of estrogen metabolism on proliferation of human breast cancer. Imoto S; Mitani F; Enomoto K; Fujiwara K; Ikeda T; Kitajima M; Ishimura Y Breast Cancer Res Treat; 1997 Jan; 42(1):57-64. PubMed ID: 9116318 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. Osborne MP; Bradlow HL; Wong GY; Telang NT J Natl Cancer Inst; 1993 Dec; 85(23):1917-20. PubMed ID: 8230281 [TBL] [Abstract][Full Text] [Related]
13. Induction of CYP1A1 and CYP1B1 in T-47D human breast cancer cells by benzo[a]pyrene is diminished by arsenite. Spink DC; Katz BH; Hussain MM; Spink BC; Wu SJ; Liu N; Pause R; Kaminsky LS Drug Metab Dispos; 2002 Mar; 30(3):262-9. PubMed ID: 11854143 [TBL] [Abstract][Full Text] [Related]
14. Modulation of hepatic CYP2A1, CYP2C11, and CYP3A9 expression in adult rats by neonatal administration of tamoxifen. Kawai M; Bandiera SM; Chang TK; Poulet FM; Vancutsem PM; Bellward GD Drug Metab Dispos; 1999 Dec; 27(12):1392-8. PubMed ID: 10570019 [TBL] [Abstract][Full Text] [Related]
15. Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: a potential pathway of metabolic activation of estrogens. Weisz J; Bui QD; Roy D; Liehr JG Endocrinology; 1992 Aug; 131(2):655-61. PubMed ID: 1386303 [TBL] [Abstract][Full Text] [Related]
16. Structure-dependent induction of aryl hydrocarbon hydroxylase in human breast cancer cell lines and characterization of the Ah receptor. Harris M; Piskorska-Pliszczynska J; Zacharewski T; Romkes M; Safe S Cancer Res; 1989 Aug; 49(16):4531-5. PubMed ID: 2545344 [TBL] [Abstract][Full Text] [Related]
17. Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer. Fishman J; Schneider J; Hershcope RJ; Bradlow HL J Steroid Biochem; 1984 Apr; 20(4B):1077-81. PubMed ID: 6727352 [TBL] [Abstract][Full Text] [Related]
18. Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cells. Sica G; Iacopino F; Robustelli della Cuna G; Marchetti P; Marini L J Cancer Res Clin Oncol; 1994; 120(10):605-9. PubMed ID: 7929532 [TBL] [Abstract][Full Text] [Related]
19. Metabolism and biologic response of estrogen sulfates in hormone-dependent and hormone-independent mammary cancer cell lines. Effect of antiestrogens. Pasqualini JR; Gelly C; Nguyen BL Ann N Y Acad Sci; 1990; 595():106-16. PubMed ID: 2375600 [TBL] [Abstract][Full Text] [Related]
20. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Lykkesfeldt AE; Madsen MW; Briand P Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]